Bio Essence (BIOE) Stock Price

Bio Essence Corp, trading under the ticker BIOE with ISIN US09090C1053, is a U.S.-based company headquartered in Irvine, California. The company made its initial public offering on March 30, 2022. Bio Essence Corp operates through three subsidiaries: Bio Essence Pharmaceutical, Inc. (BEP), Bio Essence Herbal Essentials Inc. (BEH), and McBE Pharma, Inc. (McBE). BEP functions as an original equipment manufacturer (OEM) for health supplements. BEH serves the practitioners' market with herbal products available in granules, capsules, pills, and tablets, and offers special formulation services to healthcare practitioners. McBE focuses on the development, manufacturing, and sales of prescription drugs. The company provides nutritional supplements, including herbal, diet, and vitamin products, and facilitates direct connections between customers and integrative healthcare practitioners such as dietitians and nutraceutical practitioners. Bio Essence Corp does not specify its sector or industry in the provided information. The company’s business model emphasizes integrated health supplements and research-intensive products, though the nature of its research activities is not detailed. It operates without a publicly disclosed founding year, and no acquisitions or specific product names beyond the subsidiaries are mentioned. The company's operations are centered around its subsidiaries' distinct roles in the health supplement and pharmaceutical markets.